EUPRAXIA PHARMACEUTICALS INC. cotiza a 6.72 USD y tiene una capitalización bursátil de $444M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. The company's product portfolio include…
| Periodo | 2026-11 | 2026-08 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | — | — | $-0.37 | $-0.19 |
| Estimado | $-0.26 | $-0.23 | $-0.16 | $-0.19 |
| Sorpresa | — | — | -131.3% | +0.0% |
| Métrica | EPRX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -47.0% | -40.4% | -6.6% |
| ROA | -44.8% | -32.0% | -12.8% |
| Current Ratio | 15.12 | 2.84 | +12.28 |
| Debt / Equity | — | 0.28 | — |